MDxHealth SA
(NASDAQ:MDXH)
$3.17
-0.07 (-2.01%)
Open: 3:34 PM
MDXH Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
MDXH Stock Price Today
MDxHealth SA (MDXH) stock declined over -2.31% intraday to trade at $3.165 a share on NASDAQ. The stock opened with a loss of -27.86% at $2.33 and touched an intraday high of $2.39, falling -2.01% against the last close of $3.23. The MDxHealth SA in stock market went to a low of $2.25 during the session.
MDXH Stock Snapshot
$3.23
Prev. Close
86.37 Million
Market Cap
$2.25
Day Low
$2.33
Open
N/A
Number of Shares
$2.39
Day High
N/A
P/E ratio
-2.77
EPS (TTM)
1.21
Cash Flow per Share
N/A
Free Float in %
0.66
Book Value
12077.00
Volume
MDXH Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
Beta0.53
Sales or Revenue$63.69 Million
5Y Sales Change11.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryDiagnostics & Research
About Company
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Peers
Frequently Asked Questions
What is the current MDxHealth SA (MDXH) stock price?
MDxHealth SA (NASDAQ: MDXH) stock price is $3.17 in the last trading session. During the trading session, MDXH stock reached the peak price of $2.39 while $2.25 was the lowest point it dropped to. The percentage change in MDXH stock occurred in the recent session was -2.31% while the dollar amount for the price change in MDXH stock was -$0.08.
MDXH's industry and sector of operation?
The NASDAQ listed MDXH is part of Diagnostics & Research industry that operates in the broader Healthcare sector. MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Who are the executives of MDXH?
Mr. Michael K. McGarrity
Chief Executive Officer & Executive Director
Mr. Paul Marr
Executive Vice President of Sales for North America
Mr. Joseph Sollee
Executive Vice President of Corporation Devel. & Gen. Counsel
Mr. Paul Marr
Exec. VP of Sales for North America
How MDXH did perform over past 52-week?
MDXH's closing price is 0.50% higher than its 52-week low of $2.15 where as its distance from 52-week high of $8.51 is -0.66%.
How many employees does MDXH have?
Number of MDXH employees currently stands at N/A. MDXH operates from CAP Business Center, Herstal, 4040, BE.
Link for MDXH official website?
Official Website of MDXH is: https://mdxhealth.com
How do I contact MDXH?
MDXH could be contacted at phone #32 4 257 70 21 and can also be accessed through its website. MDXH operates from CAP Business Center, Herstal, 4040, BE.
How many shares of MDXH are traded daily?
MDXH stock volume for the day was 12077.00 shares. The average number of MDXH shares traded daily for last 3 months was 55.45 Thousands.
What is the market cap of MDXH currently?
The market value of MDXH currently stands at $86.37 Million with its latest stock price at $3.17 and N/A of its shares outstanding.